Forty cases of primary CNS DLBCL were subjected to targeted exome sequencing covering 413 genes, including MYD88, CD79B and PIM1. Mutational analysis recognized two groups. This evidence concerns the gene CD79B and diffuse large B-cell lymphoma of the central nervous system.